English  |  正體中文  |  简体中文  |  总笔数 :0  
造访人次 :  52758337    在线人数 :  565
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

跳至: [ 中文 ] [ 数字0-9 ] [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ]
请输入前几个字:   

显示项目 888546-888555 / 2348685 (共234869页)
<< < 88850 88851 88852 88853 88854 88855 88856 88857 88858 88859 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2020 Treatment options for COVID-19: The reality and challenges PO-REN HSUEH; Jean S.-S.;Lee P.-I.;Po-Ren Hsueh; Jean S.-S.; Lee P.-I.
臺大學術典藏 2021-09-04T06:11:49Z Treatment options for dual HCV/HBV coinfection Liu C.-J.; JIA-HORNG KAO
臺大學術典藏 2022-01-24T09:31:46Z Treatment options for dual HCV/HBV coinfection CHUN-JEN LIU; Kao J.-H.
臺大學術典藏 2022-08-12T06:29:08Z Treatment options for primary breast cancer based on sophisticated philosophy - The importance of local controls Huang C.-H.; KING-JEN CHANG
臺大學術典藏 2021-05-02T04:37:07Z Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort Liang S.-K.; Keng L.-T.; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; JANN-YUAN WANG; Ko J.-C.; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-09-17T03:21:16Z Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort SHENG-KAI LIANG; Keng L.-T.; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; Wang J.-Y.; Ko J.-C.; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-09-17T05:56:03Z Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort Liang S.-K.; LI-TA KENG; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; Wang J.-Y.; Ko J.-C.; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-10-04T07:15:37Z Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort Liang S.-K.; Keng L.-T.; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; Wang J.-Y.; JEN-CHANG KO; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-11-29T05:55:31Z Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort Liang, Sheng-Kai; Keng, Li-Ta; Chang, Chia-Hao; Wen, Yueh-Feng; Lee, Meng-Rui; CHING-YAO YANG; Wang, Jann-Yuan; Ko, Jen-Chung; Shih, Jin-Yuan; Yu, Chong-Jen
臺大學術典藏 2021-02-08T08:05:08Z Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort Jen-Chung Ko;Sheng-Kai Liang;Li-Ta Keng;Chia-Hao Chang;Yueh-Feng Wen ; Meng-Rui Lee ; Ching-Yao Yang ; Jann-Yuan Wang ; Jin-Yuan Shih ; Chong-Jen Yu; JEN-CHUNG KO; SHENG-KAI LIANG; LI-TA KENG; CHIA-HAO CHANG; Yueh-Feng Wen ; Meng-Rui Lee ; Ching-Yao Yang ; Jann-Yuan Wang ; Jin-Yuan Shih ; Chong-Jen Yu

显示项目 888546-888555 / 2348685 (共234869页)
<< < 88850 88851 88852 88853 88854 88855 88856 88857 88858 88859 > >>
每页显示[10|25|50]项目